Sanbexin Archives - Cardiac Vascular News

Tag: Sanbexin

TASTE-2 World Stroke Congress | Sanbexin ® combined with thrombectomy significantly reduces stroke disability

Neuro October 25, 2024 by Ken Dropiewski Comments are Disabled

NANJING, China, Oct. 25, 2024 /PRNewswire/ — On October 24, 2024, TASTE-2, a Chinese innovative stroke drug study led by Professor Wang Yongjun from Beijing Tiantan Hospital, was published in an oral report at the 16th World Stroke Conference (WSC): brain cell protection combined with…

Continue Reading →

Breakthrough Therapy designation for Sanbexin sublingual tablets granted by the United States Food and Drug Administration

Neuro September 4, 2024 by Ken Dropiewski Comments are Disabled

NANJING, China, Sept. 5, 2024 /PRNewswire/ — On September 2, 2024, Simcere Pharmaceuticals Group Ltd. (2096.HK) announced that Sanbexin Sublingual Tablets (Edaravone and Dexborneol sublingual tablets), an innovative drug for stroke, has been granted the Breakthrough Therapy designation…

Continue Reading →

Tag: Sanbexin

TASTE-2 World Stroke Congress | Sanbexin ® combined with thrombectomy significantly reduces stroke disability

Breakthrough Therapy designation for Sanbexin sublingual tablets granted by the United States Food and Drug Administration

Recent

BrioHealth Solutions Begins Patient Enrollment in INNOVATE Trial of BrioVAD® System for Advanced Heart Failure

Secretome Therapeutics Closes $20.4 Million Financing Round to Advance Cardiomyopathy and Heart Failure Therapies

Edwards’ SAPIEN 3 Ultra RESILIA Valve Demonstrates Continued Excellent Outcomes for Patients in Real World Data

Popular

Subscribe to Blog via Email